1,2,3,4-TETRAHYDRO-9H-PYRIDO[3,4-B]INDOLE Chemical Properties

Melting point:

206-208 °C(lit.)

Boiling point:

351.6±32.0 °C(Predicted)

Density 

1.189±0.06 g/cm3(Predicted)

storage temp. 

Keep in dark place,Sealed in dry,Room Temperature

solubility 

10mg/mL in 1N Ammonium Hydroxide in Methanol, DMSO

pka

17.78±0.20(Predicted)

form 

Powder or Crystals

color 

White to slightly yellow

InChI

InChI=1S/C11H12N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-4,12-13H,5-7H2

InChIKey

CFTOTSJVQRFXOF-UHFFFAOYSA-N

SMILES

N1C2=C(C=CC=C2)C2CCNCC1=2

LogP

1.816 (est)

CAS DataBase Reference

16502-01-5(CAS DataBase Reference)

Safety Information

Hazard Codes 

Xi

Risk Statements 

36/37/38

Safety Statements 

26-36

WGK Germany 

3

HazardClass 

IRRITANT

HS Code 

29339900

MSDS

• Language:English Provider:SigmaAldrich

1,2,3,4-TETRAHYDRO-9H-PYRIDO[3,4-B]INDOLE Usage And Synthesis

Chemical Properties

Tan Solid

Uses

1,2,3,4-Tetrahydro-β-carboline is a mitotic kinesin inhibitor as novel anti-cancer agent. It is used in the study of neurodegenerative diseases.

Application

1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole was employed in alkaloid synthesis and in studies on neurodegenerative diseases.
Reactant for synthesis of the indolyl-β-carboline alkaloid eudistomin U via IBX mediated room temperature oxidative aromatization
Reactant for preparation of neuroprotective HDAC6 inhibitors
Reactant for preparation of aminofuranopyrimidines as EGFR and Aurora A kinase inhibitors
Reactant for preparation of inhibitors of CDK4
Reactant for preparation of tetrahydrocarboline derivatives of as human 5-HT5A receptor ligands
Reactant for preparation of 5-(diaminomethyl)-2,4-aminopyrimidines as dihydrofolate reductase inhibitors and antibacterial agents

Definition

ChEBI: 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole is a member of beta-carbolines.

General Description

Ozonolysis of the enamine bond of 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole derivatives was studied.

Synthesis

1.5 g of tryptamine was dissolved in a mixed acetic acid/methanol solvent (AcOH/MeOH = 10:1, v/v) and 345 mg of paraformaldehyde was slowly added. The reaction mixture was stirred at 80 °C for 30 min. After completion of the reaction, the progress of the reaction was monitored by TLC. The reaction system was slowly poured into dilute aqueous ammonia solution (NH4OH/H2O = 1:1, v/v, 80 ml) and the pH was adjusted to 10. The organic phases were combined by extracting three times with a solvent mixture of dichloromethane/methanol (CH2Cl2/MeOH = 10:1, v/v). The organic phase was dried with anhydrous sodium sulfate, filtered and concentrated. The crude product was purified by silica gel column chromatography with dichloromethane/methanol (CH2Cl2/MeOH = 10:1, v/v) as eluent to give 1.6 g of Intermediate A in 98% yield. The product was a light yellow solid, stable at room temperature.

in vivo

IC 50

serotonin: 6.1 μM (Ki)

References

[1] CHRISTIAN O ALBERTO Michiru H Robert B Trask. Dopamine acts as a partial agonist for α2A adrenoceptor in melanin-concentrating hormone neurons.[J]. Journal of Neuroscience, 2011, 31 29: 10671-10676. DOI:10.1523/JNEUROSCI.6245-10.2011.
[2] IAIN M. MCDONALD. 2,7-Dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine as a New Template for the Design of CCK2 Receptor Antagonists[J]. Journal of Medicinal Chemistry, 2000, 43 19: 3518-3529. DOI:10.1021/jm000960w.
[3] Rommelspacher, H., Bade, P., Coper, H., et al. Inhibition of the reuptake of serotonin by tryptoline. Naunyn Schmiedebergs Arch. Pharmacol. 292(1), 93-95 (1976).
[4] Pannier, L., and Rommelspacher, H. Actions of tetrahydronorharmane (tetrahydro-β-carboline) on 5-hydroxytryptamine and dopamine mediated mechanisms. Neuropharmacology 20(1), 1-8 (1981).
[5] Rommelspacher, H., Kauffmann, H., Cohnitz, C.H., et al. Pharmacological properties of tetrahydronorharmane (tryptoline). Naunyn Schmiedebergs Arch. Pharmacol. 298(2), 83-91 (1977).

1,2,3,4-TETRAHYDRO-9H-PYRIDO[3,4-B]INDOLE(16502-01-5)Related Product Information

• BOC-L-1,2,3,4-TETRAHYDRONORHARMAN-3-CARBOXYLIC ACID
• Yohimbine
• RESCINNAMINE
• 1-TRIFLUOROMETHYL-2,3,4,9-TETRAHYDRO-1H-B-CARBOLINE
• Reserpine
• 1-METHYL-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE
• SYROSINGOPINE
• 6-METHOXY-1,2,3,4-TETRAHYDRO-9H-PYRIDO-( 3,4B)INDOLE (MAO
• Raubasine
• 1,2,3,4-TETRAHYDRO-9H-PYRIDO[3,4-B]INDOLE
• Boc-D-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-,BOC-D-1,2,3,4-TETRAHYDRO-9H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLIC ACID
• FMOC-L-1,2,3,4-TETRAHYDRO-9H-PYRIDO-[3,4-B]-INDOLE-3-CARBOXYLIC ACID
• Ethyl3,4,4a,5-tetrahydro-1h-pyrido[4,3-b]indole-2(9bh)-carboxylate
• ethyl 1,3,4,5-tetrahydro-2h-pyrido[4,3,b]indole-2-carboxylate
• 2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-B]INDOLE-8-CARBOXYLIC ACID HYDROCHLORIDE
• FMOC-D-1,2,3,4-TETRAHYDRO-9H-PYRIDO-[3,4-B]-INDOLE-3-CARBOXYLIC ACID
• 6-methoxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole HCl
• Chloropretadalafil